Overcoming “RSV identity crisis,” Moderna announced data for its investigational mRNA-1083 vaccine, BWC0977 effort to target drug-resistant pathogens, and more this week from Contagion.
Anticipated Phase 3 Trial of Hydronidone for Treating Liver Fibrosis in Chronic Hepatitis B
World Hepatitis Day: Where Do We Go From Here?
Gene Editing Therapy Receives FDA Fast Track Status in Aiming For Potential Chronic HBV Cure
Vaccine Equality vs Equity with Dr. Jacinda Abdul-Mutakabbir
Top 5 Infectious Disease News Stories Week of April 5-12
Alaska Sees HCV Reduction, But Need For Greater Test-And-Treat Adoption Remains